NM_000243.3:c.306T>C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000243.3(MEFV):​c.306T>C​(p.Asp102Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.457 in 1,612,084 control chromosomes in the GnomAD database, including 175,423 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.47 ( 17586 hom., cov: 33)
Exomes 𝑓: 0.46 ( 157837 hom. )

Consequence

MEFV
NM_000243.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:1B:16O:1

Conservation

PhyloP100: -0.0840

Publications

41 publications found
Variant links:
Genes affected
MEFV (HGNC:6998): (MEFV innate immunity regulator, pyrin) This gene encodes a protein, also known as pyrin or marenostrin, that is an important modulator of innate immunity. Mutations in this gene are associated with Mediterranean fever, a hereditary periodic fever syndrome. [provided by RefSeq, Jul 2008]
MEFV Gene-Disease associations (from GenCC):
  • familial Mediterranean fever
    Inheritance: AD, AR, SD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, ClinGen
  • autosomal recessive familial Mediterranean fever
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • familial Mediterranean fever, autosomal dominant
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 16-3254762-A-G is Benign according to our data. Variant chr16-3254762-A-G is described in ClinVar as Benign. ClinVar VariationId is 36509.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.084 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.544 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MEFVNM_000243.3 linkc.306T>C p.Asp102Asp synonymous_variant Exon 2 of 10 ENST00000219596.6 NP_000234.1 O15553-2
MEFVNM_001198536.2 linkc.277+1549T>C intron_variant Intron 1 of 8 NP_001185465.2 O15553-3D2DTW2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MEFVENST00000219596.6 linkc.306T>C p.Asp102Asp synonymous_variant Exon 2 of 10 1 NM_000243.3 ENSP00000219596.1 O15553-2

Frequencies

GnomAD3 genomes
AF:
0.472
AC:
71757
AN:
152018
Hom.:
17555
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.506
Gnomad AMI
AF:
0.410
Gnomad AMR
AF:
0.554
Gnomad ASJ
AF:
0.393
Gnomad EAS
AF:
0.154
Gnomad SAS
AF:
0.214
Gnomad FIN
AF:
0.514
Gnomad MID
AF:
0.307
Gnomad NFE
AF:
0.475
Gnomad OTH
AF:
0.465
GnomAD2 exomes
AF:
0.443
AC:
109255
AN:
246370
AF XY:
0.426
show subpopulations
Gnomad AFR exome
AF:
0.507
Gnomad AMR exome
AF:
0.616
Gnomad ASJ exome
AF:
0.399
Gnomad EAS exome
AF:
0.163
Gnomad FIN exome
AF:
0.516
Gnomad NFE exome
AF:
0.480
Gnomad OTH exome
AF:
0.451
GnomAD4 exome
AF:
0.456
AC:
665515
AN:
1459948
Hom.:
157837
Cov.:
57
AF XY:
0.448
AC XY:
325088
AN XY:
726320
show subpopulations
African (AFR)
AF:
0.503
AC:
16823
AN:
33476
American (AMR)
AF:
0.610
AC:
27268
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.403
AC:
10527
AN:
26134
East Asian (EAS)
AF:
0.147
AC:
5824
AN:
39698
South Asian (SAS)
AF:
0.217
AC:
18744
AN:
86250
European-Finnish (FIN)
AF:
0.506
AC:
26109
AN:
51604
Middle Eastern (MID)
AF:
0.317
AC:
1827
AN:
5766
European-Non Finnish (NFE)
AF:
0.479
AC:
532232
AN:
1111924
Other (OTH)
AF:
0.433
AC:
26161
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
21764
43528
65291
87055
108819
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15528
31056
46584
62112
77640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.472
AC:
71845
AN:
152136
Hom.:
17586
Cov.:
33
AF XY:
0.469
AC XY:
34896
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.506
AC:
20996
AN:
41486
American (AMR)
AF:
0.554
AC:
8462
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.393
AC:
1365
AN:
3472
East Asian (EAS)
AF:
0.154
AC:
799
AN:
5180
South Asian (SAS)
AF:
0.214
AC:
1032
AN:
4828
European-Finnish (FIN)
AF:
0.514
AC:
5448
AN:
10592
Middle Eastern (MID)
AF:
0.310
AC:
91
AN:
294
European-Non Finnish (NFE)
AF:
0.475
AC:
32301
AN:
67978
Other (OTH)
AF:
0.464
AC:
978
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1954
3909
5863
7818
9772
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
628
1256
1884
2512
3140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.474
Hom.:
62790
Bravo
AF:
0.481
Asia WGS
AF:
0.240
AC:
839
AN:
3478
EpiCase
AF:
0.457
EpiControl
AF:
0.459

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:16Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3Other:1
-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

Allele frequency is common in at least one population database (frequency: 61.662% in ExAC) based on the frequency threshold of 1.904% for this gene. Variant was observed in a homozygous state in population databases more than expected for disease. A synonymous variant not located in a splice region. -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 27, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -

not specified Benign:5
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 88% of patients studied by a panel of primary immunodeficiencies. Number of patients: 84. Only high quality variants are reported. -

Dec 14, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Familial Mediterranean fever Benign:5
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 18, 2011
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing;curation

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Oct 08, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Autoinflammatory syndrome Benign:1
Dec 12, 2016
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial Mediterranean fever, autosomal dominant Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
1.6
DANN
Benign
0.26
PhyloP100
-0.084
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs224225; hg19: chr16-3304762; COSMIC: COSV54819764; API